Healthcare market in Brazil.
Of the approximately 6,642 hospitals, 63% are private. As of 2021, there are approximately 532,645 hospital beds (21,000 for COVID-19 patients only), 88,000 healthcare supplementary services, 502,000 physicians, 331,000 dentists, and 89,000 drugstores.
Brazil’s Unified Healthcare System (SUS) is the primary provider of health services to at least 70% of the population. In addition to medical diagnostics and treatment, the public system provides free medication for some chronic diseases and promotes national vaccination programs, mostly focused on the elderly and children.
Additionally, the Ministry of Health has been regulating and encouraging the expansion of Complementary and Integrative Practices in the public system, mostly at the municipal level.
ANVISA is the counterpart of the FDA and regulates all health-related products. While certain low risk products may be exempt from registration, it is mandatory to have an importer or distributor for product liability.
Also, it is recommended that foreign companies have local technical staff and replacement parts available locally for customer support.
Quality is also important, and companies must meet all sanitary registration requirements to sell to the government. Foreign companies should consider cost-saving measure and make the benefits of new technologies in marketing and promotional materials abundantly clear.
An aging population and poor management of resources in the healthcare sector offer opportunities for U.S. products and services.